posted on 2023-09-11, 09:40authored byBal ´ azs Nagy, Tam´ as Zelei, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Mo¨ lken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, La´ szlo´ Szilberhorn
<p dir="ltr"><a href="">Appendix Table </a>1 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the NTRK case study</p><p dir="ltr"><a href="">Appendix Table </a>2 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the ToxNav case study</p><p dir="ltr"><a href="">Appendix Table </a>3 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the MODY case study</p><p dir="ltr"><br></p>
Funding
Horizon 2020 Framework Programme, (Grant / Award Number: '824997')